Mangoceuticals, Common Financials
| MGRX Stock | 2.65 0.15 6.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.07 | 3.8775 |
|
|
The financial analysis of Mangoceuticals, Common is a critical element in measuring its lifeblood. Investors should not minimize Mangoceuticals, Common's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Mangoceuticals, |
Understanding current and past Mangoceuticals, Common Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Mangoceuticals, Common's financial statements are interrelated, with each one affecting the others. For example, an increase in Mangoceuticals, Common's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Mangoceuticals, Common's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mangoceuticals, Common Stock. Check Mangoceuticals, Common's Beneish M Score to see the likelihood of Mangoceuticals, Common's management manipulating its earnings.
Mangoceuticals, Common Stock Summary
Mangoceuticals, Common competes with FOXO Technologies, Healthcare Triangle, Bullfrog, and EUDA Health. Mangoceuticals, Common is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 56270V106 |
| Location | Texas; U.S.A |
| Business Address | 15110 North Dallas |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.mangoceuticals.com |
| Phone | (214) 242 9619 |
Mangoceuticals, Common Key Financial Ratios
| Return On Equity | -1.08 | ||||
| Operating Margin | (13.05) % | ||||
| Price To Sales | 7.60 X | ||||
| Revenue | 731.49 K | ||||
| Gross Profit | 4.85 K |
Mangoceuticals, Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mangoceuticals, Common's current stock value. Our valuation model uses many indicators to compare Mangoceuticals, Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mangoceuticals, Common competition to find correlations between indicators driving Mangoceuticals, Common's intrinsic value. More Info.Mangoceuticals, Common Stock is regarded second in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Mangoceuticals, Common's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mangoceuticals, Common's earnings, one of the primary drivers of an investment's value.Mangoceuticals, Common Systematic Risk
Mangoceuticals, Common's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mangoceuticals, Common volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Mangoceuticals, Common correlated with the market. If Beta is less than 0 Mangoceuticals, Common generally moves in the opposite direction as compared to the market. If Mangoceuticals, Common Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mangoceuticals, Common is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mangoceuticals, Common is generally in the same direction as the market. If Beta > 1 Mangoceuticals, Common moves generally in the same direction as, but more than the movement of the benchmark.
Mangoceuticals, Common November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mangoceuticals, Common help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mangoceuticals, Common Stock. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mangoceuticals, Common Stock based on widely used predictive technical indicators. In general, we focus on analyzing Mangoceuticals, Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mangoceuticals, Common's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 37.65 | |||
| Value At Risk | (10.11) | |||
| Potential Upside | 7.29 |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.